First-of-its-kind randomized clinical trial published in "the lancet infectious diseases" outlines potential new standard-setting best practices for peripheral iv catheters

Franklin lakes, n.j., feb. 2, 2021 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced that new clinical data have found robust evidence that using a vascular care solution can help improve outcomes for patients...

BDX Ratings Summary

BDX Quant Ranking